India is seeking a larger role in multinational clinical research, and the argument is increasingly about more than cost. In a recent interview with Pharma Industrial India, Dr. Seema Pai, President of the Indian Society for Clinical Research (ISCR), described India’s growing ambitions in global clinical trials. Her comments focused...